MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Operating Cash Flow 2011-2026 | NEOG
Annual Operating Cash Flow Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 58.2 M | 35.3 M | 41 M | 68 M | 81.1 M | 85.9 M | 63.8 M | 69.1 M | 60.3 M | 35.3 M | - | 21.7 M | 26.6 M | 22.3 M | 28.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 85.9 M | 21.7 M | 49.8 M |
Quarterly Operating Cash Flow Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 10.9 M | - | - | - | -17.9 M | - | - | - | 23 M | - | - | - | -14.1 M | -32.9 M | - | - | 23.2 M | 41.1 M | - | - | 25.1 M | 47.5 M | - | - | 23.7 M | 40.5 M | 23.7 M | - | 16.1 M | 32.6 M | 16.1 M | - | 18.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.51 M | 10.7 M | - | - | 4.44 M | 11.3 M | 4.44 M | - | 1.35 M | 6.17 M | 1.35 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.5 M | -32.9 M | 13.4 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 113.56 | -1.11 % | $ 34.5 B |  USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.43 | -2.19 % | $ 929 M | USA |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.35 | 0.28 % | $ 176 M |  China |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 7.94 | -1.0 % | $ 1.02 B | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
738 M | $ 166.63 | -0.95 % | $ 8.26 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 189.61 | -1.29 % | $ 135 B | USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.04 | 1.25 % | $ 696 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 14.62 | -4.82 % | $ 1.9 B | USA |
 |
DexCom
DXCM
|
1.44 B | $ 63.13 | -0.09 % | $ 24.6 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 16.16 | -1.58 % | $ 489 M | USA |
 |
Guardant Health
GH
|
-185 M | $ 90.23 | 0.63 % | $ 11.3 B | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.58 | -0.39 % | $ 83.7 K | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.13 | -1.61 % | $ 4.89 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 108.25 | -1.25 % | $ 8.93 B |  Irlanda |
 |
Illumina
ILMN
|
837 M | $ 126.36 | -1.08 % | $ 20.1 B | USA |
 |
BioNano Genomics
BNGO
|
-16.3 M | $ 1.14 | -0.54 % | $ 6.21 M | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.98 | 0.51 % | $ 8.76 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 274.19 | -0.1 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 75.95 | 0.08 % | $ 5.13 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 115.01 | 0.69 % | $ 5.38 B | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 495.15 | -0.17 % | $ 14.3 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.61 | -1.39 % | $ 427 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 200.49 | 0.72 % | $ 22.3 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.15 | -1.04 % | $ 384 M | USA |
 |
Natera
NTRA
|
-432 M | $ 206.41 | 0.75 % | $ 20.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-5.18 M | $ 4.6 | -2.95 % | $ 3.62 M | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.39 | -2.46 % | $ 417 M | USA |
 |
Precipio
PRPO
|
685 K | $ 26.0 | 0.08 % | $ 41.7 M | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 6.11 | -7.14 % | $ 362 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |